Ying Dai

A novel composite residual viable tumor score redefines prognosis in oral squamous cell carcinoma following neoadjuvant immunochemotherapy

Standard ypTNM staging may not capture residual viable tumor (RVT) across primary and nodal sites after neoadjuvant immunochemotherapy (NICT) for locally advanced oral squamous cell carcinoma (OSCC). Our aim was to derive and internally evaluate a composite RVT score. This retros...